Tara Maddala

5.5k total citations · 1 hit paper
44 papers, 1.8k citations indexed

About

Tara Maddala is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Tara Maddala has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 22 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Tara Maddala's work include Cancer Genomics and Diagnostics (15 papers), Prostate Cancer Treatment and Research (14 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Tara Maddala is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Prostate Cancer Treatment and Research (14 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Tara Maddala collaborates with scholars based in United States, Canada and United Kingdom. Tara Maddala's co-authors include F. Reed Johnson, Kathryn A. Phillips, Phillip G. Febbo, Frederick L. Baehner, Dejan Knezevic, Athanasios C. Tsiatis, Steven Shak, Eric A. Klein, Sara M. Falzarano and Cristina Magi‐Galluzzi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

Tara Maddala

42 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

2014 447 citations Eric A. Klein, Matthew R. Cooperberg et al. European Urology profile →

Peers

Countries citing papers authored by Tara Maddala

Since Specialization

Citations

This map shows the geographic impact of Tara Maddala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Maddala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Maddala more than expected).

Fields of papers citing papers by Tara Maddala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Maddala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Maddala. The network helps show where Tara Maddala may publish in the future.

Co-authorship network of co-authors of Tara Maddala

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Maddala. A scholar is included among the top collaborators of Tara Maddala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Maddala. Tara Maddala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus 2025 ·The American Journal of Gastroenterology ·(unknown), Lisa Kann, (unknown), (unknown), Suji Kim, (unknown), (unknown), Andrew Kalra, Ke Ma, Yulan Cheng, Cadman L. Leggett, Ali H. Zaidi, Ashten N. Omstead, Louis Y. Korman, Blair A. Jobe, Lorrie A. Perpetua, Bruce D. Greenwald, Tara Maddala, Stephen J. Meltzer	5
2	Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett’s Esophagus 2024 ·Diagnostics ·(unknown), (unknown), Suji Kim, (unknown), Tara Maddala, (unknown), Stephen J. Meltzer, Lisa Kann	0
3	Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection 2023 ·Cancer Research ·Peter J. Mazzone, Kwok‐Kin Wong, Jun-Chieh J. Tsay, Harvey I. Pass, Anil Vachani, (unknown), Jacob Carey, (unknown), Tony Wu, (unknown), (unknown), Keith Lumbard, (unknown), Nicholas C. Dracopoli, Tara Maddala, Peter B. Bach, Robert B. Scharpf, Victor E. Velculescu	2
4	Abstract 3372: Cell-free DNA (cfDNA) fragment length patterns of tumor- and blood-derived variants in participants with and without cancer 2019 ·Earl Hubbell, Tara Maddala, Oliver Venn, Eric Scott, Susan Tang, Archana Shenoy, Alex Aravanis	1
5	The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status 2018 ·Urology ·Cristina Magi‐Galluzzi, Sudhir Isharwal, Sara M. Falzarano, Athanasios C. Tsiatis, Anne Dee, Tara Maddala, Dejan Knezevic, Phillip G. Febbo, Jeffrey Lawrence, Eric A. Klein	6
6	A 17-gene genomic prostate score (GPS) as a predictor of biochemical (BCR) and clinical recurrence (CR) in men with surgically treated intermediate- and high-risk prostate cancer (PCa). 2016 ·Journal of Clinical Oncology ·Eric A. Klein, Timothy C. Brand, Inger L. Rosner, Nan Zhang, Michael Crager, Tara Maddala, Phillip G. Febbo, Shibu Thomas, Michael Gormley, Deborah Ricci, Sara M. Falzarano, Cristina Magi‐Galluzzi, Jennifer Cullen, Isabell A. Sesterhenn, H. Jeffrey Lawrence	1
7	Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect 2016 ·Oncotarget ·Cristina Magi‐Galluzzi, Tara Maddala, Sara M. Falzarano, Diana B. Cherbavaz, Nan Zhang, Dejan Knezevic, Phillip G. Febbo, Mark Lee, H. Jeffrey Lawrence, Eric A. Klein	17
8	PD-012 Validation study of the 12-gene Recurrence Score (RS) in patients (pts) with stage II and III colon cancer (CC) without adjuvant chemotherapy; SUNRISE Study 2015 ·Annals of Oncology ·Masataka Ikeda, Takeharu Yamanaka, Kentaro Yamazaki, Kensei Yamaguchi, Kei Muro, Tamon Kusumoto, Hiroyuki Uetake, Takeo Sato, Takaharu Kato, Tomohiro Nishina, Akiyoshi Kanazawa, Eiji Oki, Calvin Chao, Tara Maddala, (unknown), Kiwamu Akagi, A. Ochiai, Yasuo Ohashi, Atsushi Ohtsu, Takayuki Yoshino	2
9	Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score 2015 ·Urology ·Timothy C. Brand, Nan Zhang, Michael Crager, Tara Maddala, Anne Dee, Isabell A. Sesterhenn, Jeffry Simko, Matthew R. Cooperberg, Shiv Srivastava, Inger L. Rosner, June M. Chan, Phillip G. Febbo, Peter R. Carroll, Jennifer Cullen, H. Jeffrey Lawrence	37
10	A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer 2014 ·European Urology ·Jennifer Cullen, Inger L. Rosner, Timothy C. Brand, Nan Zhang, Athanasios C. Tsiatis, Joel T. Moncur, Amina Ali, Yongmei Chen, Dejan Knezevic, Tara Maddala, H. Jeffrey Lawrence, Phillip G. Febbo, Shiv Srivastava, Isabell A. Sesterhenn, David G. McLeod	231
11	A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling breakdown → 2014 ·European Urology ·Eric A. Klein, Matthew R. Cooperberg, Cristina Magi‐Galluzzi, Jeffry Simko, Sara M. Falzarano, Tara Maddala, June M. Chan, Jianbo Li, Janet E. Cowan, Athanasios C. Tsiatis, Diana B. Cherbavaz, Robert J. Pelham, (unknown), Frederick L. Baehner, Dejan Knezevic, Phillip G. Febbo, Steven Shak, Michael W. Kattan, Mark Lee, Peter R. Carroll	447
12	Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer 2011 ·British Journal of Cancer ·Joffre Baker, Debjani Dutta, Drew Watson, Tara Maddala, Brian Munneke, S. Shak, (unknown), (unknown), Christopher Harbison, Edwin Clark, David J. Mauro, Shirin Khambata‐Ford	81
13	Quantitative gene expression in primary and highest Gleason pattern cancer specimens identifies genes associated with clinical recurrence and prostate cancer–specific survival after radical prostatectomy. 2011 ·Journal of Clinical Oncology ·Eric A. Klein, Sara M. Falzarano, Tara Maddala, (unknown), Robert J. Pelham, William Novotny, Steven Shak, C. Magi-Galluzzi	1
14	Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories 2010 ·Journal of Clinical Oncology ·Frederick L. Baehner, Ninah Achacoso, Tara Maddala, S. Shak, Charles P. Quesenberry, Lynn C. Goldstein, Allen M. Gown, Laurel A. Habel	91
15	HER2 concordance between central laboratory immunohistochemistry and quantitative reverse transcription polymerase chain reaction in Intergroup Trial E2197 2008 ·Journal of Clinical Oncology ·(unknown), Robert P. Gray, Barrett H. Childs, Tara Maddala, (unknown), Steven Shak, Nancy E. Davidson, G. W. Sledge, Lori J. Goldstein, Joseph A. Sparano, S Badve	4
16	Evaluation of tumor gene expression and K-Ras mutations in FFPE tumor tissue as predictors of response to cetuximab in metastatic colorectal cancer 2008 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Tara Maddala, S. Shak, Eric K. Rowinsky, Lei Xu, (unknown), David J. Mauro, Shirin Khambata‐Ford	8
17	Concordance of local and central laboratory hormone and HER2 receptor status in ECOG 2197 2007 ·Journal of Clinical Oncology ·Sunil Badve, Frederick L. Baehner, Robert J. Gray, Barrett H. Childs, Tara Maddala, (unknown), Steven Shak, Nancy E. Davidson, Lori J. Goldstein, J. A. Sparano	2
18	An experiment on simplifying conjoint analysis designs for measuring preferences 2003 ·Health Economics ·Tara Maddala, Kathryn A. Phillips, F. Reed Johnson	81
19	Measuring Preferences for Health Care Interventions Using Conjoint Analysis: An Application to HIV Testing 2002 ·Health Services Research ·Kathryn A. Phillips, Tara Maddala, F. Reed Johnson	185
20	Measuring What People Value: A Comparison of “Attitude” and “Preference” Surveys 2002 ·Health Services Research ·Kathryn A. Phillips, F. Reed Johnson, Tara Maddala	146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact